2164-55-8 Usage
Uses
Used in Pharmaceutical Synthesis:
(5-methyl-2,3-dihydro-1,4-benzodioxin-2-yl)methanol is used as an intermediate in the pharmaceutical industry for the synthesis of various drugs. Its unique chemical structure allows for the creation of a wide range of medicinal compounds, contributing to the development of new treatments and therapies.
Used in Fragrance Production:
In the fragrance industry, (5-methyl-2,3-dihydro-1,4-benzodioxin-2-yl)methanol is used as a key component in the creation of various scent profiles. Its ability to react with other compounds and contribute to the overall scent makes it a valuable asset in the development of new fragrances.
Used as a Reagent in Organic Chemistry:
(5-methyl-2,3-dihydro-1,4-benzodioxin-2-yl)methanol is also utilized as a reagent in organic chemistry reactions. Its versatility and reactivity with other compounds make it a useful tool for researchers and chemists in the development of new chemical processes and products.
Overall, (5-methyl-2,3-dihydro-1,4-benzodioxin-2-yl)methanol is a versatile and important compound with applications in various industries, including pharmaceuticals, fragrances, and organic chemistry. Its unique properties and reactivity contribute to its value and potential for further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 2164-55-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,1,6 and 4 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 2164-55:
(6*2)+(5*1)+(4*6)+(3*4)+(2*5)+(1*5)=68
68 % 10 = 8
So 2164-55-8 is a valid CAS Registry Number.
2164-55-8Relevant academic research and scientific papers
THE REACTION OF ALKYLCYCLOHEXANONES WITH COPPER(II) BROMIDE AND 1,2-GLYCOLS
Haruta, A. Mitsuhiro,Satoh, J. Yasuo
, p. 473 - 476 (2007/10/02)
Alkylcyclohexanones react with copper(II) bromide and 1,2-glycols to give alkyl-substituted 2,3-dihydro-1,4-benzodioxin and 1,4,5,8-tetraoxapropellane derivatives.
